Filings a company makes when something has gone wrong, or is about to: a missed reporting deadline (NT 10-K/Q), a delisting from its exchange (Form 25), a deregistration that ends SEC reporting altogether (Form 15), or an insider's notice of intent to sell restricted stock (Form 144). Any one can be routine — Form 144s are filed constantly, and a late filing is sometimes just a late filing — so what is worth reading here is the pattern and the timing.
InMed Pharmaceuticals Inc. (the “Registrant”) was unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the year ended June 30, 2023 (the “Annual Report”) by th...
Due to the recent change in the auditors of InMed Pharmaceutical Inc. (the “Company”) as previously announced in the Company’s Current Report on Form 8-K filed on December 13, 2022 and a subsequent...
Loading...
